Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
trileptal filmuhúðuð tafla 300 mg
novartis healthcare a/s - oxcarbazepinum inn - filmuhúðuð tafla - 300 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
trileptal filmuhúðuð tafla 150 mg
novartis healthcare a/s - oxcarbazepinum inn - filmuhúðuð tafla - 150 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
sendoxan tafla 50 mg
baxter medical ab* - cyclophosphamidum inn - tafla - 50 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 95 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 95 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 47,5 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 47,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 23,75 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 23,75 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 190 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 190 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
sendoxan stungulyfsstofn, lausn 1 g
baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 1 g
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
sendoxan stungulyfsstofn, lausn 500 mg
baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 500 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - berklar, fjölþol-þolir - antimycobacterials - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.